tm logo
AMESOPAX
Live/Registered
REGISTERED

on 13 Aug 2024

Last Applicant/ Owned by

69120 Heidelberg

DD

Serial Number

79365161 filed on 07th Dec 2022

Registration Number

7470204 registered on 13th Aug 2024

in the Principal Register

Correspondent Address

Sean K. Owens

Sean K. Owens Wood Herron & Evans LLP

Suite 2800

Cincinnati, OH 45202

United States

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

AMESOPAX

Pharmaceutical drug development; scientific and technological services, namely, scientific research in the field of genetics; research and development services in the fields of cell diagnostics, cell therapy; scientific research for medical purposes in the field of genetics; stem cell research services; scientific research; scientific research and development; scientific research, testing and anal Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Medical services; medical diagnostic testing, monitoring and reporting services; medical assistance; health clinic services; hospital services; plastic and cosmetic surgery; medical therapies, namely, providing laser therapy for treating medical conditions; medical services in the field of regenerative medicine; medical services relating to the cultivation and procurement of stem cells; medical services in connection with the cultivation and procurement of stem cells


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [042]
Computer & Software Services & Scientific Services


Pharmaceutical drug development; scientific and technological services, namely, scientific research in the field of genetics; research and development services in the fields of cell diagnostics, cell therapy; scientific research for medical purposes in the field of genetics; stem cell research services; scientific research; scientific research and development; scientific research, testing and analysis services in the field of genetics; medical research; biomedical research services; research and development in the field of biotechnology; research and development in the field of gene therapy; research and development in the field of immunology; research and development in the field of antibodies; research and development in the field of antibody technology; research and development in the field of bacteriology; research and development in the field of gene expression systems; research and development in the field of vaccines; research and development of new products; industrial process research, namely, research and development of new products; research and development of new products for the pharmaceutical industry; research and development of new products for others; consultancy in the field of pharmaceutical research; providing information about medical and scientific research for pharmaceutical products; preparation of reports relating to scientific research


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Drugs for medical purposes, namely, pharmaceutical preparations for treating skin disorders; pharmaceutical and veterinary preparations, namely, pharmaceutical preparations for treating skin disorders; diagnostic agents, namely, diagnostic radiopharmaceutical agent for use in PET imaging; pharmaceutical preparations, namely, pharmaceutical preparations for treating skin disorders; preparations for medical purposes, namely, pharmaceutical preparations for treating skin disorders; preparations for biomedical purposes, namely, pharmaceutical preparations for treating skin disorders; pharmaceutical cell preparations for treating skin disorders; substances for medical use, namely, pharmaceutical preparations for treating skin disorders; substances for biomedical purposes, namely, pharmaceutical preparations for treating skin disorders; live implants for pharmaceutical purposes, namely, implants comprising living tissue for pharmaceutical purposes; biochemical and chemical products for medical use, namely, pharmaceutical preparations for treating skin disorders; biochemical and chemical products for pharmaceutical purposes, namely, pharmaceutical preparations for treating skin disorders; biochemical and chemical diagnostic preparations for medical purposes; proteins for medical purposes, namely, protein arrays for medical diagnosis purposes; biological preparations for medical and veterinary purposes, namely, pharmaceutical preparations for treating skin disorders; pharmaceutical and veterinary preparations for external and systemic use, namely, pharmaceutical preparations for treating skin wounds; biological, pharmaceutical and veterinary preparations for skin care for medical purposes, namely, pharmaceutical preparations for treating skin disorders; medical dressings; preparations for wound treating and healing, namely, pharmaceutical preparations for treating skin wounds; pharmaceutical preparations for treating skin wounds; stem cells for medical purposes; stem cells for veterinary purposes; somatic stem cell therapeutics, namely, somatic stem cells for medical or veterinary use; cells for medical use in the nature of fibroblasts for medical purposes; cells for medical use in the nature of fibroblasts for surgical beauty purposes; pharmaceutical implants, namely, implantable pharmaceutical preparations for treating cancer; cells for medical use in the nature of surgical implants derived from stem cells; cells for medical use in the nature of surgical implants derived from fibroblasts; cells for medical use in the nature of biological tissue for implantation; growth media for culturing cells for medical purposes; pharmaceutical preparations for tissue regeneration; vascular grafts; living tissue, namely, living cells for medical use; biotechnologically engineered tissue products, namely, cells for medical use


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [001]
Chemical Products


Stem cells for scientific use; stem cells for research use; cell growth media for growing cells for scientific use; stem cells other than for medical or veterinary purposes, namely, stem cells for aesthetic purposes excluding all medical or veterinary purposes


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79365161

Mark Type

No Service Mark

Attorney Docket Number

No MREC-6

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
13th Nov 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
13th Aug 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
13th Aug 2024REGISTERED-PRINCIPAL REGISTER
28th May 2024PUBLISHED FOR OPPOSITION
28th May 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08th May 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18th Apr 2024APPROVED FOR PUB - PRINCIPAL REGISTER
18th Apr 2024TEAS/EMAIL CORRESPONDENCE ENTERED
17th Apr 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
17th Apr 2024CORRESPONDENCE RECEIVED IN LAW OFFICE